Norethin 1/35 E Interactions
There are 467 drugs known to interact with Norethin 1/35 E (ethinyl estradiol / norethindrone), along with 24 disease interactions, and 8 alcohol/food interactions. Of the total drug interactions, 63 are major, 357 are moderate, and 47 are minor.
- View all 467 medications that may interact with Norethin 1/35 E
- View Norethin 1/35 E alcohol/food interactions (8)
- View Norethin 1/35 E disease interactions (24)
Most frequently checked interactions
View interaction reports for Norethin 1 / 35 E (ethinyl estradiol / norethindrone) and the medicines listed below.
- acetaminophen
- albuterol
- amitriptyline
- atorvastatin
- biotin
- bupropion
- buspirone
- cetirizine
- clonazepam
- cyclobenzaprine
- doxycycline
- fluoxetine
- gabapentin
- ibuprofen
- levothyroxine
- Lexapro (escitalopram)
- loratadine
- magnesium oxide
- melatonin
- meloxicam
- metformin
- multivitamin
- omeprazole
- ondansetron
- pantoprazole
- sertraline
- tizanidine
- topiramate
- trazodone
- Vitamin D3 (cholecalciferol)
Norethin 1/35 E alcohol/food interactions
There are 8 alcohol/food interactions with Norethin 1 / 35 E (ethinyl estradiol / norethindrone).
Norethin 1/35 E disease interactions
There are 24 disease interactions with Norethin 1 / 35 E (ethinyl estradiol / norethindrone) which include:
- smoking
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Norethin 1 / 35 E (ethinyl estradiol / norethindrone)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.